The Uromigos Episode 83: Is Cabozantinib the New Standard of Care in Papillary Renal Cancer?
Monty Pal discusses his randomized phase 2 study of cabozantinib in papillary renal cancer.
670 Madison Ave.
Manalapan, NJ 07726
Contributors and Partners
Cancer Nursing Today
Urban Health Today
Blood Cancers Today
© 2023 Mashup Media, LLC. All rights reserved.